|
Quotes & Info
|
| QLTI > SEC Filings for QLTI > Form 8-K on 26-Dec-2012 | All Recent SEC Filings |
26-Dec-2012
Other Events, Financial Statements and Exhibits
On December 24, 2012, QLT Inc. issued a press release announcing that the Company has entered into an exclusive option agreement with Mati Therapeutics Inc. ("Mati"), a development company associated with Robert Butchofsky, QLT's former President & CEO, under which QLT has granted Mati a 90-day option to acquire assets related to QLT's punctal plug drug delivery system technology. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
d) Exhibits
Pursuant to the rules and regulations of the Securities and Exchange Commission, the attached exhibit is deemed to have been furnished to, but not filed with, the Securities and Exchange Commission:
99.1 Press Release dated December 24, 2012
|
|